CaPre
ACA-CAP-001
Phase 3 small_molecule completed
Quick answer
CaPre for Hypertriglyceridemia is a Phase 3 program (small_molecule) at Grace Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Grace Therapeutics
- Indication
- Hypertriglyceridemia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed